£2.45m
+5%vs Jun 2024Active05148143Private limited companyAbingdon
HYPHA DISCOVERY LIMITED
Significant control: Professor Henry Joseph Beker (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Hypha Discovery Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Hypha Discovery Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
HYPHA DISCOVERY LIMITED is an active private limited company (company number 05148143) incorporated on 8 June 2004, registered in Abingdon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of £2.45m and cash of £1.00m, with 22 employees on average. Net assets rose 5% on the prior period (£2.33m).
Peer position · net assets
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Professor Henry Joseph Beker
- owns 25–50% of shares
- holds 25–50% of voting rights
- University Of Westminster
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 8 June 200422 yrs ago
- Next accounts due
- 30 March 2027in 156 days
- Confirmation statement due
- 22 June 2027in 240 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- SmallCompanies Act thresholds
05
Financials
£1.00m
−21%vs Jun 2024Not reported
22
+5%vs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £2.45m | £1.00m | £850k | £253k | — | — | 22 |
| 30 June 2024 | £2.33m | £1.27m | £822k | £302k | — | — | 21 |
Current ratio8.66Current assets ÷ creditors within one year
Cash per employee£46kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,446,852 at 30 June 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 8.66
- Cash at bank of £50,000 or moreCash £1,001,257
- Incorporated five or more years agoIncorporated 8 June 2004
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 240 days
- Next accounts duein 156 days
- Accounts period endNet assets £2.45m · small accounts
- Accounts period endNet assets £2.33m · small accounts
- Incorporated
08
Similar companies in Oxford
- CELLERON THERAPEUTICS LIMITEDOxford · inc. Jun 2004
- SUMMIT THERAPEUTICS LIMITEDAbingdon · inc. Aug 2004
- PLETHORA SOLUTIONS LIMITEDChalgrove · inc. Nov 2003
- IMUTHES LIMITEDOxford · inc. Dec 2004
- OXFORD BIOTHERAPEUTICS LTDOxford · inc. Nov 2003
- OXFORD BIOPHARMA LIMITEDOxfordshire · inc. Apr 2005
All companies incorporated on 8 June 2004 · in Jun 2004.
09
Reminders for HYPHA DISCOVERY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.